US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist
  • 5.600
  • -0.540-8.79%
Close Dec 13 16:00 ET
  • 5.710
  • +0.110+1.96%
Post 20:01 ET
317.08MMarket Cap-6.59P/E (TTM)

Design Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-13.69%16.25M
-33.43%15.04M
-33.49%14.4M
15.68%78.19M
-22.02%15.12M
-1.93%18.82M
44.48%22.6M
61.94%21.65M
88.64%67.59M
74.28%19.39M
Selling and administrative expenses
-21.47%4.37M
-18.17%4.53M
-22.33%4.6M
11.31%21.13M
-20.01%4.11M
13.85%5.57M
27.35%5.53M
28.41%5.92M
71.72%18.98M
35.54%5.14M
-General and administrative expense
-21.47%4.37M
-18.17%4.53M
-22.33%4.6M
11.31%21.13M
-20.01%4.11M
13.85%5.57M
27.35%5.53M
28.41%5.92M
71.72%18.98M
35.54%5.14M
Research and development costs
-10.42%11.88M
-38.37%10.52M
-37.69%9.8M
17.38%57.06M
-22.75%11.01M
-7.32%13.26M
51.08%17.06M
79.59%15.73M
96.19%48.61M
94.29%14.26M
Operating profit
13.69%-16.25M
33.43%-15.04M
33.49%-14.4M
-15.68%-78.19M
22.02%-15.12M
1.93%-18.82M
-44.48%-22.6M
-61.94%-21.65M
-88.64%-67.59M
-74.28%-19.39M
Net non-operating interest income expense
Other net income (expense)
5.74%3.21M
22.23%3.25M
39.80%3.3M
164.36%11.33M
59.80%3.28M
103.83%3.03M
315.47%2.66M
2,144.76%2.36M
1,337.92%4.29M
3,209.68%2.05M
Other non- operating income (expenses)
5.74%3.21M
22.23%3.25M
39.80%3.3M
164.36%11.33M
59.80%3.28M
103.83%3.03M
315.47%2.66M
2,144.76%2.36M
1,337.92%4.29M
3,209.68%2.05M
Income before tax
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
Income tax
Net income
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
Net income continuous Operations
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
Minority interest income
Net income attributable to the parent company
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
Basic earnings per share
17.86%-0.23
41.67%-0.21
42.86%-0.2
-4.39%-1.19
32.26%-0.21
12.50%-0.28
-33.33%-0.36
-45.83%-0.35
-48.05%-1.14
-55.00%-0.31
Diluted earnings per share
17.86%-0.23
41.67%-0.21
42.86%-0.2
-4.39%-1.19
32.26%-0.21
12.50%-0.28
-33.33%-0.36
-45.83%-0.35
-48.05%-1.14
-55.00%-0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -13.69%16.25M-33.43%15.04M-33.49%14.4M15.68%78.19M-22.02%15.12M-1.93%18.82M44.48%22.6M61.94%21.65M88.64%67.59M74.28%19.39M
Selling and administrative expenses -21.47%4.37M-18.17%4.53M-22.33%4.6M11.31%21.13M-20.01%4.11M13.85%5.57M27.35%5.53M28.41%5.92M71.72%18.98M35.54%5.14M
-General and administrative expense -21.47%4.37M-18.17%4.53M-22.33%4.6M11.31%21.13M-20.01%4.11M13.85%5.57M27.35%5.53M28.41%5.92M71.72%18.98M35.54%5.14M
Research and development costs -10.42%11.88M-38.37%10.52M-37.69%9.8M17.38%57.06M-22.75%11.01M-7.32%13.26M51.08%17.06M79.59%15.73M96.19%48.61M94.29%14.26M
Operating profit 13.69%-16.25M33.43%-15.04M33.49%-14.4M-15.68%-78.19M22.02%-15.12M1.93%-18.82M-44.48%-22.6M-61.94%-21.65M-88.64%-67.59M-74.28%-19.39M
Net non-operating interest income expense
Other net income (expense) 5.74%3.21M22.23%3.25M39.80%3.3M164.36%11.33M59.80%3.28M103.83%3.03M315.47%2.66M2,144.76%2.36M1,337.92%4.29M3,209.68%2.05M
Other non- operating income (expenses) 5.74%3.21M22.23%3.25M39.80%3.3M164.36%11.33M59.80%3.28M103.83%3.03M315.47%2.66M2,144.76%2.36M1,337.92%4.29M3,209.68%2.05M
Income before tax 17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M
Income tax
Net income 17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M
Net income continuous Operations 17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M
Minority interest income
Net income attributable to the parent company 17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M
Basic earnings per share 17.86%-0.2341.67%-0.2142.86%-0.2-4.39%-1.1932.26%-0.2112.50%-0.28-33.33%-0.36-45.83%-0.35-48.05%-1.14-55.00%-0.31
Diluted earnings per share 17.86%-0.2341.67%-0.2142.86%-0.2-4.39%-1.1932.26%-0.2112.50%-0.28-33.33%-0.36-45.83%-0.35-48.05%-1.14-55.00%-0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data